Michael S Boger

Comparative In Vitro Efficacies of Various Catheter Lock Solutions

Robert J. Sherertz, Michael S Boger, Casey A. Collins et al. · Antimicrobial Agents and Chemotherapy · 2006 · 111 citations · Full text

Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial

Zelalem Temesgen, Charles D. Burger, Jason Baker et al. · The Lancet Respiratory Medicine · 2021 · 70 citations · Full text

Covid-19 Pandemic, Respiratory Infection, Infectious Respiratory Disease +6

Highly Sensitive C-Reactive Protein, Body Mass Index, and Serum Lipids in HIV-Infected Persons Receiving Antiretroviral Therapy: A Longitudinal Study

Michael S Boger, Ayumi Shintani, Leigh Anne Redhage et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2009 · 38 citations

Impact of a rapid multiplex polymerase chain reaction blood culture identification technology on outcomes in patients with vancomycin-resistant <i>Enterococcal</i> bacteremia

Shawn H. MacVane, John M. Hurst, Michael S Boger et al. · Infectious Diseases · 2016 · 38 citations

The Phosphatidylinositol 3-Kinase Pathway Selectively Controls sIL-1RA Not Interleukin-1β Production in the Septic Leukocytes

Chris A. Learn, Michael S Boger, Liwu Li et al. · Journal of Biological Chemistry · 2001 · 31 citations · Full text